ECSP982761A - CELECOXIB COMPOSITIONS - Google Patents

CELECOXIB COMPOSITIONS

Info

Publication number
ECSP982761A
ECSP982761A ECSP982761A ECSP982761A EC SP982761 A ECSP982761 A EC SP982761A EC SP982761 A ECSP982761 A EC SP982761A EC SP982761 A ECSP982761 A EC SP982761A
Authority
EC
Ecuador
Prior art keywords
celecoxib compositions
celecoxib
cyclooxygenase
disorders
treatment
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Margaret B Woodhull Vaughn
Danchen Gao
Anthony HLINAK
Ahmad M Mazhary
James E Truelove
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982761 priority Critical patent/ECSP982761A/en
Publication of ECSP982761A publication Critical patent/ECSP982761A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se relaciona con composiciones farmacéuticas orales útiles en el tratamiento de ciclooxigenasa-2-, condiciones mediana y/o desórdenes que comprende un agente activo de celecoxib en una cantidad desde aproximadamente 10 mg a aproximadamente 1000mg y uno o más materiales portadores.The invention relates to oral pharmaceutical compositions useful in the treatment of cyclooxygenase-2, median conditions and / or disorders comprising a celecoxib active agent in an amount of from about 10mg to about 1000mg and one or more carrier materials.

ECSP982761 1998-11-30 1998-11-30 CELECOXIB COMPOSITIONS ECSP982761A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982761 ECSP982761A (en) 1998-11-30 1998-11-30 CELECOXIB COMPOSITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982761 ECSP982761A (en) 1998-11-30 1998-11-30 CELECOXIB COMPOSITIONS

Publications (1)

Publication Number Publication Date
ECSP982761A true ECSP982761A (en) 1999-05-06

Family

ID=42043680

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982761 ECSP982761A (en) 1998-11-30 1998-11-30 CELECOXIB COMPOSITIONS

Country Status (1)

Country Link
EC (1) ECSP982761A (en)

Similar Documents

Publication Publication Date Title
BR9810495A (en) Pharmaceutical composition
BG66093B1 (en) Controlled release compositions comprising nimesulide
ATE246514T1 (en) MEDICINAL PRODUCTS CONTAINING PACLITAXEL
DZ2964A1 (en) New substituted diphenylureas, and pharmaceutical compositions containing them.
CR6210A (en) CELECOXIB COMPOSITIONS
ATE293995T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS THAT PROMOTE DRUG ABSORPTION
BRPI0519212A2 (en) oral disintegrating pharmaceutical compositions containing sensory manifestation agents
SG147485A1 (en) Pharmaceutical compositions for prevention of overdose or abuse
MY125651A (en) Eplerenone compositions
SE0003449D0 (en) Anticancer compositions
WO2002051424A8 (en) Drugs against articular failure
ATE460921T1 (en) MEDICINAL COMPOSITION IN AEROSOL FORM
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
UY27598A1 (en) PHARMACEUTICAL COMPOSITIONS OF ORXALLY ACTIVE TAXAN DERIVATIVES THAT HAVE IMPROVED BIODISPONIBILITY
SE0102843D0 (en) Stabilized oral pharmaceutical composition containing lodide and lodate and method
UY26715A1 (en) EMULSIONS WITH NAPHTHALATE ESTERS
WO2005007137A3 (en) Tablets containing ambroxol
MXPA04001398A (en) Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine.
CO5190674A1 (en) TREATMENT OF NEUROTIC DISORDERS NEUROTIC DISORDERS
BR0010708A (en) Androgenic glycosides and androgenic activity
AU6469401A (en) Pharmaceutically active compounds and methods of use
FR2801218B1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING TRIMEGESTONE, THEIR PREPARATION METHODS AND THE PRIMARY PACKAGING CONTAINING THEM
AR037131A1 (en) RIBAVIRINA SYRUP FORMULATIONS
MA27102A1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF IVABRADINE
ES2192420T3 (en) USE OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ANTI-TARGET AGENT AND AT LEAST ONE PEPTIDE.